Hong Kong
# |
Name |
Gross Profit |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 5.55 B
|
Dec. 31, 2023 | USD 0.67 | 1.53% |
|
Hong Kong |
|
2 |
USD 2.99 B
|
Dec. 31, 2023 | USD 0.37 | 1.03% |
|
Hong Kong |
|
3 |
USD 2.08 B
|
Dec. 31, 2023 | USD 14.74 | 7.67% |
|
Hong Kong |
|
4 |
USD 1.31 B
|
Dec. 31, 2023 | USD 0.26 | 1.45% |
|
Hong Kong |
|
5 |
USD 892.26 M
|
Dec. 31, 2023 | USD 1.42 | 0.70% |
|
Hong Kong |
|
6 |
USD 860.48 M
|
Dec. 31, 2023 | USD 0.91 | -0.72% |
|
Hong Kong |
|
7 |
USD 816.15 M
|
March 31, 2024 | USD 0.43 | 2.74% |
|
Hong Kong |
|
8 |
USD 463.42 M
|
Dec. 31, 2023 | USD 0.41 | 1.55% |
|
Hong Kong |
|
9 |
USD 453.55 M
|
Dec. 31, 2023 | USD 3.02 | 2.59% |
|
Hong Kong |
|
10 |
USD 217.74 M
|
Dec. 31, 2023 | USD 0.53 | 5.07% |
|
Hong Kong |
|
11 |
USD 106.50 M
|
Dec. 31, 2023 | USD 0.47 | -0.57% |
|
Hong Kong |
|
12 |
USD 94.94 M
|
Dec. 31, 2023 | USD 0.83 | 3.07% |
|
Hong Kong |
|
13 |
USD 90.36 M
|
Dec. 31, 2023 | USD 0.15 | -0.02% |
|
Hong Kong |
|
14 |
USD 82.26 M
|
Dec. 31, 2023 | USD 0.18 | -0.02% |
|
Hong Kong |
|
15 |
USD 79.27 M
|
March 31, 2024 | USD 0.13 | 1.98% |
|
Hong Kong |
|
16 |
USD 78.39 M
|
Dec. 31, 2023 | USD 0.21 | 8.82% |
|
Hong Kong |
|
17 |
USD 70.58 M
|
Dec. 31, 2023 | USD 0.16 | -0.02% |
|
Hong Kong |
|
18 |
USD 43.19 M
|
March 31, 2024 | USD 0.22 | -1.75% |
|
Hong Kong |
|
19 |
USD 41.11 M
|
Dec. 31, 2023 | USD 0.44 | -0.60% |
|
Hong Kong |
|
20 |
USD 33.77 M
|
Dec. 31, 2023 | USD 0.21 | 10.11% |
|
Hong Kong |
|
21 |
USD 21.46 M
|
Dec. 31, 2023 | USD 0.31 | 0.39% |
|
Hong Kong |
|
22 |
USD 8.83 M
|
Dec. 31, 2023 | USD 5.81 | -1.19% |
|
Hong Kong |
|
23 |
USD 6.52 M
|
June 30, 2024 | USD 0.20 | 1.98% |
|
Hong Kong |
|
24 |
USD 1.29 M
|
Dec. 31, 2023 | USD 0.10 | 0.02% |
|
Hong Kong |
|
25 |
USD 397.00 K
|
Dec. 31, 2023 | USD 0.39 | 0.30% |
|
Hong Kong |
|
26 |
USD 59.44 K
|
Dec. 31, 2023 | USD 0.13 | -1.02% |
|
Hong Kong |
|
27 |
USD -745.59 K
|
June 30, 2024 | USD 4.86 | -4.71% |
|
Hong Kong |
The Health Care company in Hong Kong with the highest Gross Profit is China Resources Pharmaceutical Group Limited (HKSE: 3320.HK) at USD 5.55 B.
The Health Care company in Hong Kong with the lowest Gross Profit is Regencell Bioscience Holdings Limited (NasdaqCM: RGC) at USD -745.59 K.
The top 10 Health Care companies in Hong Kong by Gross Profit are China Resources Pharmaceutical Group Limited, Sino Biopharmaceutical Limited, BeiGene, Ltd., China Traditional Chinese Medicine Holdings Co. Limited, The United Laboratories International Holdings Limited, China Medical System Holdings Limited, Alibaba Health Information Technology Limited, SSY Group Limited, HUTCHMED (China) Limited and Modern Dental Group Limited.
The bottom 10 Health Care companies in Hong Kong by Gross Profit are Regencell Bioscience Holdings Limited, SinoMab BioScience Limited, Sirnaomics Ltd., Yunnan Energy International Co. Limited, HKE Holdings Limited, Prenetics Global Limited, Pak Fah Yeow International Limited, Chia Tai Enterprises International Limited, Tycoon Group Holdings Limited and JBM (Healthcare) Limited.